[HTML][HTML] Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM
S Xu, YC Cheuk, Y Jia, T Chen, J Chen, Y Luo… - Cell death & …, 2022 - nature.com
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM
S Xu, YC Cheuk, Y Jia, T Chen, J Chen… - Cell Death and …, 2022 - search.proquest.com
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM.
S Xu, YC Cheuk, Y Jia, T Chen, J Chen… - Cell Death & …, 2022 - search.ebscohost.com
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
[HTML][HTML] Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM
S Xu, YC Cheuk, Y Jia, T Chen, J Chen, Y Luo… - Cell Death & …, 2022 - ncbi.nlm.nih.gov
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM
S Xu, YC Cheuk, Y Jia, T Chen, J Chen… - Cell death & …, 2022 - pubmed.ncbi.nlm.nih.gov
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM.
S Xu, YC Cheuk, Y Jia, T Chen, J Chen, Y Luo… - Cell Death & …, 2022 - europepmc.org
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM.
S Xu, YC Cheuk, Y Jia, T Chen, J Chen, Y Luo… - Cell Death & …, 2022 - europepmc.org
Renal fibrosis is a common pathological feature and outcome of almost all chronic kidney
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …
diseases, and it is characterized by metabolic reprogramming toward aerobic glycolysis …